CHARM Therapeutics
Employs DragonFold technology for rapid protein/ligand co-folding to develop novel drugs.
Employs DragonFold technology for rapid protein/ligand co-folding to develop novel drugs.
Sector
Life SciencesCategory
AITherapeutics
Location
London, UKInitial Investment
2022CHARM Therapeutics is a 3D deep-learning research Company discovering and developing transformational medicines. Based on the award-winning discoveries of David Baker in protein-folding, CHARM has developed a proprietary technology based on the first rapid, accurate protein/ligand co-folding algorithm. The Company’s mission is to use these insights to address challenging targets in cancer and other disease areas and discover and develop new drugs against these targets.
“Without F-Prime, CHARM simply would not exist. They played a crucial role in syndicating the financing, building the initial business plan and recruiting stellar co-founders, executives and board members to the team.”
Laksh Aithani, Co-founder & CEO
